Heart attack drug trial tests new way to cool artery inflammation
NCT ID NCT07351643
Summary
This study is testing if a drug called dapagliflozin, usually used for diabetes, can reduce harmful inflammation in the heart arteries of people who have recently had a heart attack. The 110 participants do not have diabetes or heart failure. Researchers will use special heart CT scans to measure inflammation in the fat around the arteries before and after 6 months of taking the drug alongside standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACS - ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
General Hospital of Northern Theater Command
Shenyang, Liaoning, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.